You are here

  • Home
  • Archive
  • Volume 18, Issue 2
  • Cessation of donepezil is associated with clinical decline in patients with moderate-to-severe Alzheimer's disease compared to continuation of donepezil or addition or substitution of memantine

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Cessation of donepezil is associated with clinical decline in patients with moderate-to-severe Alzheimer's disease compared to continuation of donepezil or addition or substitution of memantine

https://doi.org/10.1136/eb-2012-100722

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests PNT has received consulting fees and stock options from Adamas. His institution receives research support from Pfizer and Janssen.